Bentley InnoMed GmbH announced it has been granted two TÜV certificates that extend indications for its stents in complex ...

Solaris Endovascular, Inc. recently announced the formation of the company, which will develop solutions for dialysis access i ...

November 20, 2024—enVVeno Medical Corporation announced 1-year data on all patients from SAVVE, the United States pivotal trial of the company&r ...

Xeltis recently announced that the FDA has granted Breakthrough Device designation for the company’s aXess vascular acce ...

Simcere Pharmaceuticals Group Ltd. recently announced that findings from the TASTE-2 clinical study have shown that the admini ...

Healionics Corporation announced that its Stargraft arteriovenous (AV) graft for dialysis access has been granted ...

Arsenal Medical announced the initiation of the EMBO-02 clinical study of its NeoCast liquid embolic to treat chronic ...

Humacyte, Inc. recently announced the presentation of results from the V007 phase 3 clinical trial of the company’s acel ...

R3 Vascular Inc. recently announced that the FDA granted investigational device exemption (IDE) approval to initiate the compa ...

November 8, 2024—Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced recently that the FDA has approved its investigational device exemption (IDE) application ...

November 7, 2024—CVRx, Inc. announced recently that the Centers for Medicare and Medicaid Services (CMS) assigned the company’s Barostim procedure to New Technology Ambulatory Payment Classification ...

The ELEGANCE registry, which is focused on historically underrepresented minorities and women, analyzed endovascular treatment ...